Searched for
LIQUIDITY ADJUSTMENT FACILITY
RBI's Rs 2.5 lakh crore liquidity infusion raises questions over tightening policy signal: SBI ReportIn its report, SBI said the RBI had consistently signalled its commitment to monetary tightening through its policy resolution, the Governo...
Global Market: Bank Indonesia defends policy mix after market confusionBank Indonesia has defended its latest policy package combining an unchanged benchmark rate, a higher deposit facility rate and reserve req...
RBI injects Rs 1 lakh crore as liquidity tightens before festive seasonOn Monday, the RBI announced a Rs 1-lakh-crore variable rate repo (VRR) auction for the first time since late July after the weighted avera...
RBI Repo Rate 2026: Malhotra & Co hike repo rate by 25 bps to 5.50% for first time in nearly 4 years as inflation pressures buildRepo Rate Hike: The RBI raised the repo rate by 25 basis points to 5.50%, its first hike in nearly four years, as rising oil prices, a weak...
RBI MPC Key Takeaways 2026: Repo rate hiked to 5.50%, FY27 GDP growth forecast raised to 7.1%RBI Monetary Policy 2026 Takeaways: The Reserve Bank of India raised the repo rate by 25 basis points to 5.50%, the first increase since Fe...
PNB, Kotak Mahindra Bank, other bank stocks rise up to 2% after RBI’s rate hike, Nifty Bank above 55,500Bank stocks including Kotak Mahindra Bank, PNB, Union Bank and Canara Bank gained up to 2% after the RBI rose on Monday after the repo rate...
These mid-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of over 25%, according to analystsWhat is needed in the markets these days is realism. Not fear or gloom, but a clear-eyed acceptance of where things actually stand. Realism...
ET Prime Special Series: Multibagger or IBC - Part 78: A tech company hiding inside an auto-parts maker. But with a weak spotThis is one of the most exciting businesses in the sector: A technology company disguised as an auto-parts maker, growing fast, earning exc...
5 stocks with consistent score improvement and upside potential of up to 26% in 1 year, according to analystsWhen fear and uncertainty are the primary feelings on the street, the ability to rationally deal with negative news drops sharply. That is ...
In 1858, Gundlach Bundschu began a California wine legacy. 168 years later, pandemic fallout, heavy debt and a changing market have pushed the historic winery into bankruptcyGundlach Bundschu Winery, founded in California in 1858, has filed for Chapter 11 bankruptcy protection. The winery seeks to restructure ov...
Short-term headwinds, long-term calm: 6 mid-cap stocks from different sectors with upside potential of up to 22%This is not the time to expect that every stock you own will do well; or that you will make quick and easy gains. If you are entering the m...
RBI system liquidity surplus at record high: What it means for loans, FDs and investmentsA record Rs.10 trillion-plus surplus is lowering borrowing costs, but complicating RBI’s inflation fight.
Is senior living worth the cost? Financial trade-offs seniors and families need to consider before making the moveAs families shrink and longevity rises, senior living offers independence, companionship and security. But the comfort comes at a real cost.
In 1970, NASA’s Apollo 13 Mission nearly turned deadly. One woman’s invention saved lives. Her son became a Hollywood starHollywood star Jack Black’s late mother Judith Love Cohen was a heavyweight in her own right. An aerospace engineer, her invention played a...
Gland Pharma block deal: Fosun Pharma divests 99 lakh shares worth Rs 2,800 croreFosun Pharma sold a 6% stake in Gland Pharma for ₹2,800 crore via a block deal, reducing its holding to 45.77%. Major buyers included Kotak...
Block deal alert! Gland Pharma shares fall 3% as 1.2 crore shares change hands in 2 block deals; promoter Fosun likely sellerGland Pharma shares fell after a significant block deal involving Fosun Pharma Industrial. The company's VSEZ facility received zero USFDA ...
Gland Pharma shares: Promoter Fosun Pharma likely to divest 5% equity worth Rs 2,279 crore via block dealFosun Pharma plans to divest 5% equity in Gland Pharma through a Rs 2,279.5 crore block deal at Rs 2,763 per share. Gland Pharma reported a...